dylight 550 Search Results


90
Novus Biologicals dylight 550 conjugated rabbit polyclonal antibodies against hif 1α
Cell sorting data for separation of caboxyfluorescein diactetate succinimidyl ester (CFDA-SE)-labeled bone-derived mesenchymal stem cells (BMSCs) and unlabeled nucleus pulposus cells (NPCs) following 7-day co-culture using UPAL gel. (a): Two-dimensional (2D) dot plot for co-cultured cells. The P1 gate was placed around single live cells. (b): 2D dot plot showing unlabeled NPCs in the P2 gate and CFDA-SE-labeled BMSCs in the P3 gate that were sorted. FSC-A: Forward scatter-area; FSC-W: Forward scatter-width; SSC-A: Side scatter-area; CFDA-SE-A: CFDA-SE-area. Gene expression for each cell was normalized to the housekeeping gene GAPDH and plotted on a log scale (y-axis). Data were averaged from four different rabbit NPC lines. (c): <t>HIF-1α,</t> (d): GLUT-1, (e): Brachyury, (f): CDMP-1, (g): TGF-β, (h): IGF-1, (i): type II collagen, and (j): aggrecan. Data are represented as the means ± SE. p -values were determined by one-way ANOVA with a post hoc Tukey–Kramer test.
Dylight 550 Conjugated Rabbit Polyclonal Antibodies Against Hif 1α, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dylight 550 conjugated rabbit polyclonal antibodies against hif 1α/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
dylight 550 conjugated rabbit polyclonal antibodies against hif 1α - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Novus Biologicals nbp1 48338r
Cell sorting data for separation of caboxyfluorescein diactetate succinimidyl ester (CFDA-SE)-labeled bone-derived mesenchymal stem cells (BMSCs) and unlabeled nucleus pulposus cells (NPCs) following 7-day co-culture using UPAL gel. (a): Two-dimensional (2D) dot plot for co-cultured cells. The P1 gate was placed around single live cells. (b): 2D dot plot showing unlabeled NPCs in the P2 gate and CFDA-SE-labeled BMSCs in the P3 gate that were sorted. FSC-A: Forward scatter-area; FSC-W: Forward scatter-width; SSC-A: Side scatter-area; CFDA-SE-A: CFDA-SE-area. Gene expression for each cell was normalized to the housekeeping gene GAPDH and plotted on a log scale (y-axis). Data were averaged from four different rabbit NPC lines. (c): <t>HIF-1α,</t> (d): GLUT-1, (e): Brachyury, (f): CDMP-1, (g): TGF-β, (h): IGF-1, (i): type II collagen, and (j): aggrecan. Data are represented as the means ± SE. p -values were determined by one-way ANOVA with a post hoc Tukey–Kramer test.
Nbp1 48338r, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nbp1 48338r/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
nbp1 48338r - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Novus Biologicals hif 1α
Cell sorting data for separation of caboxyfluorescein diactetate succinimidyl ester (CFDA-SE)-labeled bone-derived mesenchymal stem cells (BMSCs) and unlabeled nucleus pulposus cells (NPCs) following 7-day co-culture using UPAL gel. (a): Two-dimensional (2D) dot plot for co-cultured cells. The P1 gate was placed around single live cells. (b): 2D dot plot showing unlabeled NPCs in the P2 gate and CFDA-SE-labeled BMSCs in the P3 gate that were sorted. FSC-A: Forward scatter-area; FSC-W: Forward scatter-width; SSC-A: Side scatter-area; CFDA-SE-A: CFDA-SE-area. Gene expression for each cell was normalized to the housekeeping gene GAPDH and plotted on a log scale (y-axis). Data were averaged from four different rabbit NPC lines. (c): <t>HIF-1α,</t> (d): GLUT-1, (e): Brachyury, (f): CDMP-1, (g): TGF-β, (h): IGF-1, (i): type II collagen, and (j): aggrecan. Data are represented as the means ± SE. p -values were determined by one-way ANOVA with a post hoc Tukey–Kramer test.
Hif 1α, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hif 1α/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
hif 1α - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Novus Biologicals dylight 550 conjugated antibody against beclin 1
Cell sorting data for separation of caboxyfluorescein diactetate succinimidyl ester (CFDA-SE)-labeled bone-derived mesenchymal stem cells (BMSCs) and unlabeled nucleus pulposus cells (NPCs) following 7-day co-culture using UPAL gel. (a): Two-dimensional (2D) dot plot for co-cultured cells. The P1 gate was placed around single live cells. (b): 2D dot plot showing unlabeled NPCs in the P2 gate and CFDA-SE-labeled BMSCs in the P3 gate that were sorted. FSC-A: Forward scatter-area; FSC-W: Forward scatter-width; SSC-A: Side scatter-area; CFDA-SE-A: CFDA-SE-area. Gene expression for each cell was normalized to the housekeeping gene GAPDH and plotted on a log scale (y-axis). Data were averaged from four different rabbit NPC lines. (c): <t>HIF-1α,</t> (d): GLUT-1, (e): Brachyury, (f): CDMP-1, (g): TGF-β, (h): IGF-1, (i): type II collagen, and (j): aggrecan. Data are represented as the means ± SE. p -values were determined by one-way ANOVA with a post hoc Tukey–Kramer test.
Dylight 550 Conjugated Antibody Against Beclin 1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dylight 550 conjugated antibody against beclin 1/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
dylight 550 conjugated antibody against beclin 1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Novus Biologicals monoclonal mouse anti gfap
Cell sorting data for separation of caboxyfluorescein diactetate succinimidyl ester (CFDA-SE)-labeled bone-derived mesenchymal stem cells (BMSCs) and unlabeled nucleus pulposus cells (NPCs) following 7-day co-culture using UPAL gel. (a): Two-dimensional (2D) dot plot for co-cultured cells. The P1 gate was placed around single live cells. (b): 2D dot plot showing unlabeled NPCs in the P2 gate and CFDA-SE-labeled BMSCs in the P3 gate that were sorted. FSC-A: Forward scatter-area; FSC-W: Forward scatter-width; SSC-A: Side scatter-area; CFDA-SE-A: CFDA-SE-area. Gene expression for each cell was normalized to the housekeeping gene GAPDH and plotted on a log scale (y-axis). Data were averaged from four different rabbit NPC lines. (c): <t>HIF-1α,</t> (d): GLUT-1, (e): Brachyury, (f): CDMP-1, (g): TGF-β, (h): IGF-1, (i): type II collagen, and (j): aggrecan. Data are represented as the means ± SE. p -values were determined by one-way ANOVA with a post hoc Tukey–Kramer test.
Monoclonal Mouse Anti Gfap, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal mouse anti gfap/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
monoclonal mouse anti gfap - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

92
Novus Biologicals lightning link rapid dylight 550 antibody labeling kit
Cell sorting data for separation of caboxyfluorescein diactetate succinimidyl ester (CFDA-SE)-labeled bone-derived mesenchymal stem cells (BMSCs) and unlabeled nucleus pulposus cells (NPCs) following 7-day co-culture using UPAL gel. (a): Two-dimensional (2D) dot plot for co-cultured cells. The P1 gate was placed around single live cells. (b): 2D dot plot showing unlabeled NPCs in the P2 gate and CFDA-SE-labeled BMSCs in the P3 gate that were sorted. FSC-A: Forward scatter-area; FSC-W: Forward scatter-width; SSC-A: Side scatter-area; CFDA-SE-A: CFDA-SE-area. Gene expression for each cell was normalized to the housekeeping gene GAPDH and plotted on a log scale (y-axis). Data were averaged from four different rabbit NPC lines. (c): <t>HIF-1α,</t> (d): GLUT-1, (e): Brachyury, (f): CDMP-1, (g): TGF-β, (h): IGF-1, (i): type II collagen, and (j): aggrecan. Data are represented as the means ± SE. p -values were determined by one-way ANOVA with a post hoc Tukey–Kramer test.
Lightning Link Rapid Dylight 550 Antibody Labeling Kit, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lightning link rapid dylight 550 antibody labeling kit/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
lightning link rapid dylight 550 antibody labeling kit - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

90
Novus Biologicals monoclonal rat anti human cd11b dylight550
Cell sorting data for separation of caboxyfluorescein diactetate succinimidyl ester (CFDA-SE)-labeled bone-derived mesenchymal stem cells (BMSCs) and unlabeled nucleus pulposus cells (NPCs) following 7-day co-culture using UPAL gel. (a): Two-dimensional (2D) dot plot for co-cultured cells. The P1 gate was placed around single live cells. (b): 2D dot plot showing unlabeled NPCs in the P2 gate and CFDA-SE-labeled BMSCs in the P3 gate that were sorted. FSC-A: Forward scatter-area; FSC-W: Forward scatter-width; SSC-A: Side scatter-area; CFDA-SE-A: CFDA-SE-area. Gene expression for each cell was normalized to the housekeeping gene GAPDH and plotted on a log scale (y-axis). Data were averaged from four different rabbit NPC lines. (c): <t>HIF-1α,</t> (d): GLUT-1, (e): Brachyury, (f): CDMP-1, (g): TGF-β, (h): IGF-1, (i): type II collagen, and (j): aggrecan. Data are represented as the means ± SE. p -values were determined by one-way ANOVA with a post hoc Tukey–Kramer test.
Monoclonal Rat Anti Human Cd11b Dylight550, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal rat anti human cd11b dylight550/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
monoclonal rat anti human cd11b dylight550 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Novus Biologicals anti vim
Cell sorting data for separation of caboxyfluorescein diactetate succinimidyl ester (CFDA-SE)-labeled bone-derived mesenchymal stem cells (BMSCs) and unlabeled nucleus pulposus cells (NPCs) following 7-day co-culture using UPAL gel. (a): Two-dimensional (2D) dot plot for co-cultured cells. The P1 gate was placed around single live cells. (b): 2D dot plot showing unlabeled NPCs in the P2 gate and CFDA-SE-labeled BMSCs in the P3 gate that were sorted. FSC-A: Forward scatter-area; FSC-W: Forward scatter-width; SSC-A: Side scatter-area; CFDA-SE-A: CFDA-SE-area. Gene expression for each cell was normalized to the housekeeping gene GAPDH and plotted on a log scale (y-axis). Data were averaged from four different rabbit NPC lines. (c): <t>HIF-1α,</t> (d): GLUT-1, (e): Brachyury, (f): CDMP-1, (g): TGF-β, (h): IGF-1, (i): type II collagen, and (j): aggrecan. Data are represented as the means ± SE. p -values were determined by one-way ANOVA with a post hoc Tukey–Kramer test.
Anti Vim, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti vim/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
anti vim - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Novus Biologicals anti sox10 antibody
(A) Experimental strategy. Oligodendrocytes (OL; n = 66 PTA, n = 20 MDA) and neurons (n = 56 PTA) were obtained from the brains of 20 neurotypical individuals (0–104 years of age) through FANS using NEUN (neurons) and <t>SOX10</t> (OL) antibodies. Single genomes were amplified using PTA or MDA and non-clonal somatic SNVs (sSNVs) and indels were called using SCAN2. Mutation distributions were compared with snATAC-seq and snRNA-seq data obtained from a subset of the 20 individuals. (B) Integrated Genomics Viewer screenshots of two sSNVs identified by SCAN2. Top, an sSNV shared by two oligodendrocytes; bottom, a private sSNV in a neuron. (C) Extrapolated genome-wide sSNV and indel burdens for OLs and neurons as a function of age. SCAN2 estimates mutation burdens for each single cell individually by adjusting for sensitivity. Trend lines are mixed-effects linear regression models; outlier single cells with abnormally high or low mutation burdens, indicated by crosses, were excluded from the linear regressions (see ). (D) Distribution of OL and neuronal sSNVs and indels in annotated gene regions. Enrichment/depletion levels are calculated by comparison with a null distribution obtained by randomly shuffling mutations across the genome followed by correction for somatic mutation detection sensitivity; error bars represent bootstrapped 95% CIs (see ). Percentages give the observed mutation count divided by the expected mutation count from the null distribution in each region. (E) Percent of somatic mutations in the total mutation catalog with HIGH, MODERATE, and LOW impact on genes, as determined by SnpEff. See also , , , and and , , and .
Anti Sox10 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti sox10 antibody/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
anti sox10 antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Novus Biologicals vimentin dylight 550
(A) Experimental strategy. Oligodendrocytes (OL; n = 66 PTA, n = 20 MDA) and neurons (n = 56 PTA) were obtained from the brains of 20 neurotypical individuals (0–104 years of age) through FANS using NEUN (neurons) and <t>SOX10</t> (OL) antibodies. Single genomes were amplified using PTA or MDA and non-clonal somatic SNVs (sSNVs) and indels were called using SCAN2. Mutation distributions were compared with snATAC-seq and snRNA-seq data obtained from a subset of the 20 individuals. (B) Integrated Genomics Viewer screenshots of two sSNVs identified by SCAN2. Top, an sSNV shared by two oligodendrocytes; bottom, a private sSNV in a neuron. (C) Extrapolated genome-wide sSNV and indel burdens for OLs and neurons as a function of age. SCAN2 estimates mutation burdens for each single cell individually by adjusting for sensitivity. Trend lines are mixed-effects linear regression models; outlier single cells with abnormally high or low mutation burdens, indicated by crosses, were excluded from the linear regressions (see ). (D) Distribution of OL and neuronal sSNVs and indels in annotated gene regions. Enrichment/depletion levels are calculated by comparison with a null distribution obtained by randomly shuffling mutations across the genome followed by correction for somatic mutation detection sensitivity; error bars represent bootstrapped 95% CIs (see ). Percentages give the observed mutation count divided by the expected mutation count from the null distribution in each region. (E) Percent of somatic mutations in the total mutation catalog with HIGH, MODERATE, and LOW impact on genes, as determined by SnpEff. See also , , , and and , , and .
Vimentin Dylight 550, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vimentin dylight 550/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
vimentin dylight 550 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Novus Biologicals novus nbp1 54467r
(A) Experimental strategy. Oligodendrocytes (OL; n = 66 PTA, n = 20 MDA) and neurons (n = 56 PTA) were obtained from the brains of 20 neurotypical individuals (0–104 years of age) through FANS using NEUN (neurons) and <t>SOX10</t> (OL) antibodies. Single genomes were amplified using PTA or MDA and non-clonal somatic SNVs (sSNVs) and indels were called using SCAN2. Mutation distributions were compared with snATAC-seq and snRNA-seq data obtained from a subset of the 20 individuals. (B) Integrated Genomics Viewer screenshots of two sSNVs identified by SCAN2. Top, an sSNV shared by two oligodendrocytes; bottom, a private sSNV in a neuron. (C) Extrapolated genome-wide sSNV and indel burdens for OLs and neurons as a function of age. SCAN2 estimates mutation burdens for each single cell individually by adjusting for sensitivity. Trend lines are mixed-effects linear regression models; outlier single cells with abnormally high or low mutation burdens, indicated by crosses, were excluded from the linear regressions (see ). (D) Distribution of OL and neuronal sSNVs and indels in annotated gene regions. Enrichment/depletion levels are calculated by comparison with a null distribution obtained by randomly shuffling mutations across the genome followed by correction for somatic mutation detection sensitivity; error bars represent bootstrapped 95% CIs (see ). Percentages give the observed mutation count divided by the expected mutation count from the null distribution in each region. (E) Percent of somatic mutations in the total mutation catalog with HIGH, MODERATE, and LOW impact on genes, as determined by SnpEff. See also , , , and and , , and .
Novus Nbp1 54467r, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/novus nbp1 54467r/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
novus nbp1 54467r - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Novus Biologicals spcas9 mouse monoclonal antibody
(A) Experimental strategy. Oligodendrocytes (OL; n = 66 PTA, n = 20 MDA) and neurons (n = 56 PTA) were obtained from the brains of 20 neurotypical individuals (0–104 years of age) through FANS using NEUN (neurons) and <t>SOX10</t> (OL) antibodies. Single genomes were amplified using PTA or MDA and non-clonal somatic SNVs (sSNVs) and indels were called using SCAN2. Mutation distributions were compared with snATAC-seq and snRNA-seq data obtained from a subset of the 20 individuals. (B) Integrated Genomics Viewer screenshots of two sSNVs identified by SCAN2. Top, an sSNV shared by two oligodendrocytes; bottom, a private sSNV in a neuron. (C) Extrapolated genome-wide sSNV and indel burdens for OLs and neurons as a function of age. SCAN2 estimates mutation burdens for each single cell individually by adjusting for sensitivity. Trend lines are mixed-effects linear regression models; outlier single cells with abnormally high or low mutation burdens, indicated by crosses, were excluded from the linear regressions (see ). (D) Distribution of OL and neuronal sSNVs and indels in annotated gene regions. Enrichment/depletion levels are calculated by comparison with a null distribution obtained by randomly shuffling mutations across the genome followed by correction for somatic mutation detection sensitivity; error bars represent bootstrapped 95% CIs (see ). Percentages give the observed mutation count divided by the expected mutation count from the null distribution in each region. (E) Percent of somatic mutations in the total mutation catalog with HIGH, MODERATE, and LOW impact on genes, as determined by SnpEff. See also , , , and and , , and .
Spcas9 Mouse Monoclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spcas9 mouse monoclonal antibody/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
spcas9 mouse monoclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Cell sorting data for separation of caboxyfluorescein diactetate succinimidyl ester (CFDA-SE)-labeled bone-derived mesenchymal stem cells (BMSCs) and unlabeled nucleus pulposus cells (NPCs) following 7-day co-culture using UPAL gel. (a): Two-dimensional (2D) dot plot for co-cultured cells. The P1 gate was placed around single live cells. (b): 2D dot plot showing unlabeled NPCs in the P2 gate and CFDA-SE-labeled BMSCs in the P3 gate that were sorted. FSC-A: Forward scatter-area; FSC-W: Forward scatter-width; SSC-A: Side scatter-area; CFDA-SE-A: CFDA-SE-area. Gene expression for each cell was normalized to the housekeeping gene GAPDH and plotted on a log scale (y-axis). Data were averaged from four different rabbit NPC lines. (c): HIF-1α, (d): GLUT-1, (e): Brachyury, (f): CDMP-1, (g): TGF-β, (h): IGF-1, (i): type II collagen, and (j): aggrecan. Data are represented as the means ± SE. p -values were determined by one-way ANOVA with a post hoc Tukey–Kramer test.

Journal: EBioMedicine

Article Title: Bone marrow mesenchymal stem cells combined with ultra-purified alginate gel as a regenerative therapeutic strategy after discectomy for degenerated intervertebral discs

doi: 10.1016/j.ebiom.2020.102698

Figure Lengend Snippet: Cell sorting data for separation of caboxyfluorescein diactetate succinimidyl ester (CFDA-SE)-labeled bone-derived mesenchymal stem cells (BMSCs) and unlabeled nucleus pulposus cells (NPCs) following 7-day co-culture using UPAL gel. (a): Two-dimensional (2D) dot plot for co-cultured cells. The P1 gate was placed around single live cells. (b): 2D dot plot showing unlabeled NPCs in the P2 gate and CFDA-SE-labeled BMSCs in the P3 gate that were sorted. FSC-A: Forward scatter-area; FSC-W: Forward scatter-width; SSC-A: Side scatter-area; CFDA-SE-A: CFDA-SE-area. Gene expression for each cell was normalized to the housekeeping gene GAPDH and plotted on a log scale (y-axis). Data were averaged from four different rabbit NPC lines. (c): HIF-1α, (d): GLUT-1, (e): Brachyury, (f): CDMP-1, (g): TGF-β, (h): IGF-1, (i): type II collagen, and (j): aggrecan. Data are represented as the means ± SE. p -values were determined by one-way ANOVA with a post hoc Tukey–Kramer test.

Article Snippet: For HIF-1α, GLUT-1, and Brachyury staining, DyLight 550-conjugated rabbit polyclonal antibodies against HIF-1α (Novus Biologicals, Centennial, CO, USA; NB100-479R, RRID: AB_1642267), PE-conjugated rabbit polyclonal antibody against GLUT-1 (LS Bio, Seattle, WA, USA; LS-A109342-100), and unconjugated rabbit polyclonal antibodies against Brachyury (LS Bio; LS-C31179-100, RRID: AB_911118) were applied.

Techniques: FACS, Labeling, Derivative Assay, Co-Culture Assay, Cell Culture, Gene Expression

Nucleus pulposus (NP) marker-positive cells in rabbit NPs. (a-c): Horizontal sections of rabbit intervertebral discs (IVDs) stained for HIF-1α, GLUT-1, and Brachyury at days 1, 7, and 28. Images are representative of four replicates (Intact control, Discectomy, and BMSCs + Gel, n = 4; days 1, 7, and 28). Scale bar = 50 μm. (d–f): Percentages of NP marker-positive cells relative to total cells. (g–i): Percentages of NP marker-positive cells relative to CFDA-SE-positive cells (representative of implanted BMSCs). Data are the means ± SE. p -values were determined using the paired t -test.

Journal: EBioMedicine

Article Title: Bone marrow mesenchymal stem cells combined with ultra-purified alginate gel as a regenerative therapeutic strategy after discectomy for degenerated intervertebral discs

doi: 10.1016/j.ebiom.2020.102698

Figure Lengend Snippet: Nucleus pulposus (NP) marker-positive cells in rabbit NPs. (a-c): Horizontal sections of rabbit intervertebral discs (IVDs) stained for HIF-1α, GLUT-1, and Brachyury at days 1, 7, and 28. Images are representative of four replicates (Intact control, Discectomy, and BMSCs + Gel, n = 4; days 1, 7, and 28). Scale bar = 50 μm. (d–f): Percentages of NP marker-positive cells relative to total cells. (g–i): Percentages of NP marker-positive cells relative to CFDA-SE-positive cells (representative of implanted BMSCs). Data are the means ± SE. p -values were determined using the paired t -test.

Article Snippet: For HIF-1α, GLUT-1, and Brachyury staining, DyLight 550-conjugated rabbit polyclonal antibodies against HIF-1α (Novus Biologicals, Centennial, CO, USA; NB100-479R, RRID: AB_1642267), PE-conjugated rabbit polyclonal antibody against GLUT-1 (LS Bio, Seattle, WA, USA; LS-A109342-100), and unconjugated rabbit polyclonal antibodies against Brachyury (LS Bio; LS-C31179-100, RRID: AB_911118) were applied.

Techniques: Marker, Staining, Control

(A) Experimental strategy. Oligodendrocytes (OL; n = 66 PTA, n = 20 MDA) and neurons (n = 56 PTA) were obtained from the brains of 20 neurotypical individuals (0–104 years of age) through FANS using NEUN (neurons) and SOX10 (OL) antibodies. Single genomes were amplified using PTA or MDA and non-clonal somatic SNVs (sSNVs) and indels were called using SCAN2. Mutation distributions were compared with snATAC-seq and snRNA-seq data obtained from a subset of the 20 individuals. (B) Integrated Genomics Viewer screenshots of two sSNVs identified by SCAN2. Top, an sSNV shared by two oligodendrocytes; bottom, a private sSNV in a neuron. (C) Extrapolated genome-wide sSNV and indel burdens for OLs and neurons as a function of age. SCAN2 estimates mutation burdens for each single cell individually by adjusting for sensitivity. Trend lines are mixed-effects linear regression models; outlier single cells with abnormally high or low mutation burdens, indicated by crosses, were excluded from the linear regressions (see ). (D) Distribution of OL and neuronal sSNVs and indels in annotated gene regions. Enrichment/depletion levels are calculated by comparison with a null distribution obtained by randomly shuffling mutations across the genome followed by correction for somatic mutation detection sensitivity; error bars represent bootstrapped 95% CIs (see ). Percentages give the observed mutation count divided by the expected mutation count from the null distribution in each region. (E) Percent of somatic mutations in the total mutation catalog with HIGH, MODERATE, and LOW impact on genes, as determined by SnpEff. See also , , , and and , , and .

Journal: Cell

Article Title: Contrasting somatic mutation patterns in aging human neurons and oligodendrocytes

doi: 10.1016/j.cell.2024.02.025

Figure Lengend Snippet: (A) Experimental strategy. Oligodendrocytes (OL; n = 66 PTA, n = 20 MDA) and neurons (n = 56 PTA) were obtained from the brains of 20 neurotypical individuals (0–104 years of age) through FANS using NEUN (neurons) and SOX10 (OL) antibodies. Single genomes were amplified using PTA or MDA and non-clonal somatic SNVs (sSNVs) and indels were called using SCAN2. Mutation distributions were compared with snATAC-seq and snRNA-seq data obtained from a subset of the 20 individuals. (B) Integrated Genomics Viewer screenshots of two sSNVs identified by SCAN2. Top, an sSNV shared by two oligodendrocytes; bottom, a private sSNV in a neuron. (C) Extrapolated genome-wide sSNV and indel burdens for OLs and neurons as a function of age. SCAN2 estimates mutation burdens for each single cell individually by adjusting for sensitivity. Trend lines are mixed-effects linear regression models; outlier single cells with abnormally high or low mutation burdens, indicated by crosses, were excluded from the linear regressions (see ). (D) Distribution of OL and neuronal sSNVs and indels in annotated gene regions. Enrichment/depletion levels are calculated by comparison with a null distribution obtained by randomly shuffling mutations across the genome followed by correction for somatic mutation detection sensitivity; error bars represent bootstrapped 95% CIs (see ). Percentages give the observed mutation count divided by the expected mutation count from the null distribution in each region. (E) Percent of somatic mutations in the total mutation catalog with HIGH, MODERATE, and LOW impact on genes, as determined by SnpEff. See also , , , and and , , and .

Article Snippet: Pellets containing nuclei were resuspended in ice-cold PBS 1X supplemented with 3mM MgCl 2 , then filtered, blocked in PBS 1X supplemented with 3mM MgCl 2 and 3% Bovine Serum Albumin (blocking solution), and stained with an anti-NEUN antibody (Millipore MAB377) previously used for neuronal nuclei isolation, , anti-SOX10 antibody (Novus NBP2-59621R), and DAPI.

Techniques: Amplification, Mutagenesis, Genome Wide, Comparison

KEY RESOURCES TABLE

Journal: Cell

Article Title: Contrasting somatic mutation patterns in aging human neurons and oligodendrocytes

doi: 10.1016/j.cell.2024.02.025

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Pellets containing nuclei were resuspended in ice-cold PBS 1X supplemented with 3mM MgCl 2 , then filtered, blocked in PBS 1X supplemented with 3mM MgCl 2 and 3% Bovine Serum Albumin (blocking solution), and stained with an anti-NEUN antibody (Millipore MAB377) previously used for neuronal nuclei isolation, , anti-SOX10 antibody (Novus NBP2-59621R), and DAPI.

Techniques: Whole Genome Amplification, Binding Assay, dsDNA Assay, Multiplex Assay, Sequencing, Software